Highlights vTv Therapeutics Inc.

Equities

VTVT

US9183852048

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-01 pm EDT			5-day change	1st Jan Change
27.96 ^USD	+0.22%		+11.95%	+143.13%

Mar. 14	VTv Therapeutics Inc. Announces Board Changes	CI
Mar. 13	VTv Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

VTv Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 13	CI
VTv Therapeutics Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 13	CI
VTv Therapeutics Inc. Announces FDA Submission for First Phase 3 Study of Cadisegliatin in Patients with Type 1 Diabetes	Mar. 04	CI
VTv Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 09	CI
VTv Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-11	CI
Cantex Pharmaceuticals Receives US Patent Covering vTv Therapeutics' Azeliragon	23-05-24	MT
VTv Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-11	CI
Earnings Flash (VTVT) VTV THERAPEUTICS Reports Q4 Revenue $9,000	23-03-06	MT
VTV THERAPEUTICS INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	23-03-06	AQ
VTv Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-06	CI
VTv Therapeutics Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-03-06	CI
VTv Therapeutics Appoints Biotech Industry Veteran Steven Tuch as Chief Financial Officer	22-12-13	AQ
VTv Therapeutics Inc. Appoints Steven Tuch as Chief Financial Officer	22-12-13	CI
VTv Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-10	CI
VTv Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-15	CI
VTv Therapeutics Gets $10 Million Investment from CinRx Pharma	22-07-25	MT
VTv Therapeutics Announces Publication in Diabetes Obesity and Metabolism of Complete Results for the Mechanistic Study Assessing Effects of TTP399 on Ketones during Acute Insulin Withdrawal in Patients with Type 1 Diabetes	22-06-04	CI
VTV Therapeutics Joins Forces with G42 Investments, Secures Investment	22-06-01	MT
VTv Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-12	CI
VTV THERAPEUTICS INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	22-03-29	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights vTv Therapeutics Inc.

Equities

VTVT

US9183852048

Highlights

Filters